Glaxosmithkline Cons Company Profile
✉ Email this page to a colleague
What is the competitive landscape for GLAXOSMITHKLINE CONS, and what generic and branded alternatives to GLAXOSMITHKLINE CONS drugs are available?
GLAXOSMITHKLINE CONS has two approved drugs.
Summary for Glaxosmithkline Cons
| US Patents: | 0 |
| Tradenames: | 1 |
| Ingredients: | 1 |
| NDAs: | 2 |
| PTAB Cases with Glaxosmithkline Cons as petitioner: | See PTAB cases with Glaxosmithkline Cons as petitioner |
Drugs and US Patents for Glaxosmithkline Cons
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Glaxosmithkline Cons | THRIVE | nicotine polacrilex | GUM, CHEWING;BUCCAL | 077656-001 | Jun 19, 2007 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
| Glaxosmithkline Cons | THRIVE | nicotine polacrilex | GUM, CHEWING;BUCCAL | 077658-001 | Jun 19, 2007 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
